Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the application for quotation of 717,587 new fully paid ordinary securities on the ASX, with the issue date set for April 9, 2024. This move indicates a significant step for the company as it seeks to expand its financial base and presence in the market.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
